Evaluate Rituximab Treatment for Idiopathic Membranous Nephropathy
Condition(s):Idiopathic Membranous NephropathyLast Updated:October 26, 2021Completed
Hide Studies Not Open or Pending
Condition(s):Idiopathic Membranous NephropathyLast Updated:October 26, 2021Completed
Condition(s):Nephrotic Syndrome; Proteinuria; Autoimmune Disease; Glomerular Disease; Membranous GlomerulonephritisLast Updated:March 22, 2024Recruiting
Condition(s):Focal Segmental GlomerulosclerosisLast Updated:March 8, 2023Recruiting
Condition(s):Edema; Hypervolemia; Chronic Kidney Diseases; Nephrotic SyndromeLast Updated:November 22, 2023Recruiting
Condition(s):EfficacyLast Updated:February 17, 2022Completed
Condition(s):Secondary (AA) Amyloidosis; Rheumatoid Arthritis; Nephrotic Syndrome; Familial Mediterranean Syndrome; Kidney Diseases; Gastrointestinal DiseasesLast Updated:February 14, 2006Completed
Condition(s):ProteinuriaLast Updated:November 23, 2016Unknown status
Condition(s):Membranous NephropathyLast Updated:February 25, 2011Completed
Condition(s):Henoch Schönlein Purpura NephritisLast Updated:November 10, 2020Unknown status
Condition(s):Preeclampsia; Hypertension; Proteinuria; PregnancyLast Updated:October 16, 2015Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.